Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Don't Floss, You Lose - (ATRX) To the RESCUE. -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (9)	1/26/1999 3:25:00 PM
From: Paul Senior	Read Replies (2) \| Respond to of 182

If you like ATRX, you might also like BLOCA. Block Drug holds marketing and royalty rights to (some) ATRX products. Block buys well known brand names in niche markets and markets them (polident, for example). They are trying to expand in dental products for dentists. Paying about a 3% dividend yield, and offering a 3% stock dividend most years. Should be a more stable investment than ATRX, yet participate in benefits from ATRX association. JMO, Paul Senior (long time BLOCA shareholder)